Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia

导出原文传递

翻译打印收藏纠错

作者： Dang, Weiqi ^[1] ; Xiao, Jingfang ; Ma, Qinghua ; Miao, Jingya ; Cao, Mianfu ; Chen, Lu ; Shi, Yu ; Yao, Xiaohong ; Yu, Shichang ; Liu, Xindong ; Cui, Youhong ; Zhang, Xia ; Bian, Xiuwu

作者单位： Third Mil Med Univ, Southwest Hosp, Inst Pathol, Army Med Univ, Chongqing 400038, Peoples R China ^[1]

关键词 Glioma-associated macrophages Glioma-associated microglia p38 MAPK PD-L1 Temozolomide-resistant

发布时间 2021-11-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Brain tumor pathology

2021年38卷3期

189-200页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia

Brain tumor pathology

相似文献

Brain tumor pathology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia

Brain tumor pathology

相似文献

Brain tumor pathology

相关期刊

检索历史清除